Reviva Pharmaceuticals Holdings Inc. (RVPH): Net earnings per share for the last 12 months

Symbol and logo of brand revivapharma.com (RVPH)

Reviva Pharmaceuticals (RVPH) is mitigating clinical risks by testing a key molecule for the treatment of psoriasis and schizophrenia. The 12-month rolling EPS confirms this strategy, where -6.77 captures a new level. Development is based on automated biochemical tests, while the final stages of trials rely on collaboration with external contract research organizations.

RVPH (revivapharma.com) Net earnings per share (EPS TTM) history from 07/04/2022 to 05/16/2026

Comprehensive metric breakdowns and analytics for Reviva Pharmaceuticals Holdings (RVPH)

General company analysis:revivapharma.com (RVPH)
Mass-produced product of Reviva Pharmaceuticals Holdings Inc.

EPS TTM measures the portion of net income attributable to each common share over a trailing twelve-month period. Growth in this value confirms operational efficiency, whereas stagnation signals a "value trap" risk. By analyzing the current trailing twelve-month net income per share, an investor distinguishes a systemic crisis from a temporary downturn. For Reviva Pharmaceuticals (RVPH), this metric reflects the capital burn stage prior to commercialization. Neuropsychiatric patents are expected to transform current losses into future royalties and a stable cash flow.

Competitors of Reviva Pharmaceuticals (RVPH)

biogen.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (Neurocrine)|RGC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Axsome Therapeutics Inc|ACAD (ACADIA Corp) - Net earnings per share (EPS TTM)|XENE: Earnings per share for the trailing year|Net earnings per share for the last 12 months VKTX (Viking Therapeutics, Inc.)|Net earnings per share (EPS TTM) Supernus Pharmaceuticals, Inc. (SUPN)|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters DNLI (Denali Therapeutics Inc)|Harmony Biosciences - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BHVN (biohavenpharma.com)|AMLX: Net earnings per share (EPS TTM)|Trevi Therapeutics, Inc. - Earnings per share for the trailing year|PRAX (Praxis Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Anavex Life Sciences AVXL|Net earnings per share (EPS TTM) CBLL|PRTA (prothena.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALEC (Alector Inc.)|Net earnings per share (EPS TTM) Annexon Biosciences ANNX|Omeros Corporation - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Neurogene Therapeutics NGNE|ACIU: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Voyager Therapeutics, Inc. (VYGR)|Net earnings per share for the last 12 months NMRA|Net earnings per share for the last 12 months Scilex Holding (SCLX)|Net earnings per share (EPS TTM) TVGN|Net earnings per share for the last 12 months Alpha Cognition Inc ACOG|cogrx.com - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Inhibikase Therapeutics, Inc. IKT|SAVA - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months VistaGen Therapeutics Inc|OVID (ovidrx.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ABOS|Earnings per share for the last twelve months CervoMed Corporation (CRVO)|Net earnings per share (EPS TTM) Alterity Therapeutics Ltd (ATHE)|Earnings per share for the last twelve months clene.com CLNN|PEPG (PepGen Corp) - Earnings per one share for the last 12 months|JUNS - Earnings per share for the last twelve months|RLMD (relmada.com) - Earnings per share for the last 12 months|Annovis Bio Corporation (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics Inc - Earnings per share for the trailing year|AIFF (Firefly Neuro) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KLTO|Earnings per share for the last twelve months NeuroSense Therapeutics, Ltd. (NRSN)|Net earnings per share (EPS TTM) MetaVia, Inc. (MTVA)|NeurAxis, Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Helius Medical HSDT|PASG - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Earnings per share for the last twelve months|Athira Pharma, Inc. - Earnings per share for the trailing year|ADXN (Addex) - Net earnings per share (EPS TTM)|Alzamend Neuro, Inc. - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CYCN|PTIX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months pasitheaclinics.com KTTA|Earnings per share for the trailing year CRGT|Avenue Therapeutics Inc - Net earnings per share (EPS TTM)|Brainstorm Cell Therapeutics, Inc. (BCLI) - Net earnings per share for the last 12 months|CARA: Net earnings per share (EPS TTM)|Chromocell - Earnings per share for the trailing year|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|ITCI (intracellulartherapies.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Longboard Pharma (LBPH)|Marinus - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NKGN (nkgenbiotech.com)|NeuroBo Pharma - Earnings per share for the last twelve months|Sage Therapeutics Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Vigil Neuroscience Inc.|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year